Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care.

Select Content Type
Clinical Guidelines
Authored By
Gunn CM, Li EX, Gignac GA, Pankowska M, Loo S, Zayhowski K, Wang C
Authored On
Interests
Oncology
Obstetrics & Gynecology
Speciality
Obstetrics & Gynecology
Oncology
Book Detail
volume
30
ISSN
1526-2359
Publication Date
Actions
Download in App
Event Data
{"article_title":"Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care.","author":"Gunn CM, Li EX, Gignac GA, Pankowska M, Loo S, Zayhowski K, Wang C","journal_title":"Cancer control : journal of the Moffitt Cancer Center","issn":"1526-2359","isbn":"","publication_date":"2023 Jan-Dec","volume":"30","issue":"","first_page":"1.07327E+016","page_count":"","accession_number":"36946278","doi":"10.1177\/10732748221143884","publisher":"SAGE Publishing","doctype":"Journal Article","subjects":"Genetic Testing; Prostatic Neoplasms diagnosis; Prostatic Neoplasms genetics; Prostatic Neoplasms therapy; Male; Humans; Health Services Accessibility","interest_area":["Oncology"," Obstetrics & Gynecology"],"abstract":"Introduction: The 2018 National Comprehensive Cancer Network guidelines for prostate cancer genetic testing expanded access to genetic services. Few studies have examined how this change has affected provider practice outside of large cancer centers. Methods: We conducted a qualitative study of multi-disciplinary health care providers treating patients with prostate cancer at a safety-net hospital. Participants completed an interview that addressed knowledge, practices, and contextual factors related to providing genetic services to patients with prostate cancer. A thematic analysis using both inductive and deductive coding was undertaken. Results: Seventeen providers completed interviews. Challenges in identifying eligible patients for genetic testing stemmed from a lack of a) systems that facilitate routine patient identification, and b) readily available family history data for eligibility determination. Providers identified non-medical patient characteristics that influenced their referral process, including health literacy, language, cultural beliefs, patient distress, and cost. Providers who see patients at different times along the cancer care continuum viewed benefits of testing differently. Conclusion: The use of digital technologies that systematically identify those eligible for genetic testing referrals may mitigate some but not all challenges identified in this study. Further research should determine how individual provider perceptions influence referral practices and patient access to genetics both within and across cancer specialties.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=36946278&authtype=shib&custid=ns346513","isPdfLink":true,"isSAML":false,"additionalInfo":{"Authored_By":"Gunn CM, Li EX, Gignac GA, Pankowska M, Loo S, Zayhowski K, Wang C","Journal_Info":"Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9438457 Publication Model: Print Cited Medium: Internet ISSN: 1526-2359 (Electronic) Linking ISSN: 10732748 NLM ISO Abbreviation: Cancer Control Subsets: MEDLINE","Publication_Type":"Journal Article","Published_Date":"2023-01-01","Source":"Cancer control : journal of the Moffitt Cancer Center [Cancer Control] 2023 Jan-Dec; Vol. 30, pp. 10732748221143884.","Languages":"English","Electronic_ISSN":"1526-2359","MeSH_Terms":"Genetic Testing* , Prostatic Neoplasms*\/diagnosis , Prostatic Neoplasms*\/genetics , Prostatic Neoplasms*\/therapy, Male ; Humans ; Health Services Accessibility","Subjects":"Male, Humans, Health Services Accessibility, Genetic Testing, Prostatic Neoplasms diagnosis, Prostatic Neoplasms genetics, Prostatic Neoplasms therapy","Title_Abbreviations":"Cancer control : journal of the Moffitt Cancer Center","Volume":"30"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"36946278","RelevancyScore":"898","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"897.55908203125"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=36946278&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=36946278&authtype=shib&custid=ns346513&group=main&profile=eds"}
ISSN
1526-2359
IS_Ebsco
true
Additional Info
["Gunn CM, Li EX, Gignac GA, Pankowska M, Loo S, Zayhowski K, Wang C","Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9438457 Publication Model: Print Cited Medium: Internet ISSN: 1526-2359 (Electronic) Linking ISSN: 10732748 NLM ISO Abbreviation: Cancer Control Subsets: MEDLINE","Journal Article","2023-01-01","Cancer control : journal of the Moffitt Cancer Center [Cancer Control] 2023 Jan-Dec; Vol. 30, pp. 10732748221143884.","English","1526-2359","Genetic Testing* , Prostatic Neoplasms*\/diagnosis , Prostatic Neoplasms*\/genetics , Prostatic Neoplasms*\/therapy, Male ; Humans ; Health Services Accessibility","Male, Humans, Health Services Accessibility, Genetic Testing, Prostatic Neoplasms diagnosis, Prostatic Neoplasms genetics, Prostatic Neoplasms therapy","Cancer control : journal of the Moffitt Cancer Center","30"]
Description
Introduction: The 2018 National Comprehensive Cancer Network guidelines for prostate cancer genetic testing expanded access to genetic services. Few studies have examined how this change has affected provider practice outside of large cancer centers.<br />Methods: We conducted a qualitative study of multi-disciplinary health care providers treating patients with prostate cancer at a safety-net hospital. Participants completed an interview that addressed knowledge, practices, and contextual factors related to providing genetic services to patients with prostate cancer. A thematic analysis using both inductive and deductive coding was undertaken.<br />Results: Seventeen providers completed interviews. Challenges in identifying eligible patients for genetic testing stemmed from a lack of a) systems that facilitate routine patient identification, and b) readily available family history data for eligibility determination. Providers identified non-medical patient characteristics that influenced their referral process, including health literacy, language, cultural beliefs, patient distress, and cost. Providers who see patients at different times along the cancer care continuum viewed benefits of testing differently.<br />Conclusion: The use of digital technologies that systematically identify those eligible for genetic testing referrals may mitigate some but not all challenges identified in this study. Further research should determine how individual provider perceptions influence referral practices and patient access to genetics both within and across cancer specialties.
Published Date